About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Articles

Novel Aspects of Classification, Prognosis and Therapy in Takotsubo Syndrome

Published:

18 December 2019

Citation:

European Cardiology Review 2019;14(3):191–6

Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments

Published:

18 December 2019

Citation:

European Cardiology Review 2019;14(3):201

Testosterone and the Heart

Published:

11 July 2019

Citation:

European Cardiology Review 2019;14(2):103–10

Hidden in Heart Failure

Published:

11 July 2019

Citation:

European Cardiology Review 2019;14(2):89–96